Limatoc, Romeo L.
HRN: 64 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
04/04/2022
04/10/2022
IV
1.5grams
Q6h
Wound Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes